Five of six potential initial public offerings (IPOs) on last week’s calendar succeeded in entering the public markets with up to five more on the calendar for the coming week. Last week’s capital raise totaled $466 million reflects, not including proceeds from the IPO of a blank-check company.
Yoga studio operator YogaWorks postponed a planned offering of 5 million shares that was slated to raise $65 million at the mid-point of the expected range of $12 to $14 per share.
Calyxt Inc. (NASDAQ: CLXT) raised $56 million with an upsized offering of 7 million shares priced at $8, the low end of the expected range. Shares popped nearly 41% on the first day of trading and closed the week up 35.1%.
Blank-check firm Federal Street Acquisition Corp. (NASDAQ: FSACU) raised $400 million, selling 40 million units at $10 per unit.
Kala Pharmaceuticals Inc. (NASDAQ: KALA) sold 6 million shares at $15 a share to raise $90 million. Shares got a first-day pop of 23.3% and closed the week up 27.3%.
Top Clean Energy Stocks For 2018: Roche Holding AG (RHHBY)
Advisors’ Opinion:
- [By SEEKINGALPHA.COM]
AbbVie (ABBV) reported positive trial data from its phase 3 study of venetoclax in combination with Roches (OTCQX:RHHBY) Rituxan in patients with relapsed/refractory chronic lymphocytic leukemia (CLL) and showed the venetoclax combo extended progression-free survival compared to bendamustine + Rituxan. I recently covered AbbVie and its pipeline and argued that AbbVie has little to replace Humira with in that pipeline.
- [By SEEKINGALPHA.COM]
Medtronic operates both in the therapeutic and diagnostic medical markets throughout the world; the company’s varied product lines face a vast combination of competitors, ranging from large manufacturers with multiple business lines (exemplified by Johnson & Johnson) to smaller manufacturers offering a limited selection of products, like Insulet (NASDAQ:PODD). Other notable competitors include Abbott Labs (NYSE:ABT), C.R. Bard (NYSE:BCR), Baxter (NYSE:BAX), LivaNova (NASDAQ:LIVN), Roche (OTCQX:RHHBY), DexCom (NASDAQ:DXCM) and Tandem (NASDAQ:TNDM).
- [By SEEKINGALPHA.COM]
Current biologic top sellers in RA include AbbVie (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ), Amgen (NASDAQ:AMGN), Pfizer (NYSE:PFE), Bristol-Myers Squibb (NYSE:BMY), Roche (OTCQX:RHHBY), and UCB (OTCPK:UCBJF). The table below shows the drugs marketed by these pharmaceutical giants and relevant details:
- [By SEEKINGALPHA.COM]
Source: Biogen’ Q2 2017 Results Presentation
Tysabri sales were $496, in line with consensus. This dynamic has been helpful to reassure investors that the impact from the recent launch of Roches (OTCQX:RHHBY) Ocrevus has been limited and that the franchise could be still defended over the next 5 years.
- [By SEEKINGALPHA.COM]
There’s still a lot to love about BMY and Opdivo, as they have the potential to be much larger. Now, notable BMY buyers could be the likes of Novartis (NYSE:NVS), Roche (OTCQX:RHHBY) or Pfizer (NYSE:PFE) – PFE has been looking to up its presence in the oncology market, and is also looking for a major purchase. BMY has a strong oncology pipeline that could work well with PFE or even Gilead (NASDAQ:GILD). GILD has an interest in oncology, and has plenty of cash for a buyout.
- [By WWW.THESTREET.COM]
Novartis AG (NVS) said Monday that it has received approval from the European Commission for a blood cancer treatment known as Rixathon, a biosimilar version of Roche AG’s (RHHBY) blockbuster Rituxan that generated around $7.5 billion in sales last year.
Top Clean Energy Stocks For 2018: Dave & Buster's Entertainment, Inc.(PLAY)
Advisors’ Opinion:
- [By Nicholas Rossolillo]
Dave and Buster’s Entertainment (NASDAQ:PLAY) is unique in that it’s part restaurant, part gaming establishment. On the food side, the chain touts American gastro-pub style cuisine and an extensive bar, but the experience is what really sets Dave and Buster’s apart. Who says arcades are only for kids?
- [By Lisa Levin]
Dave & Buster's Entertainment, Inc. (NASDAQ: PLAY) shares were also up, gaining 17 percent to $56.39 after the company reported stronger-than-expected results for its third quarter and boosted its full year net income guidance.
- [By Peter Graham]
Small cap restaurant and entertainment stockDave & Busters Entertainment Inc (NASDAQ: PLAY) reported Q2 2017 earnings after the Tuesday close with shares falling in after hours/premarket trading. Total revenues increased 14.9% to $280.8 million as comparable store sales increased 1.1%. Across all stores, Food and Beverage revenues increased 10.2% to $118.7 million from $107.7 million and Amusement and Other revenues increased 18.6% to $162.1 million from $136.7 million. Food and Beverage represented 42.3% of total revenues while Amusements and Other represented 57.7% of total revenues in the Q2 2017 versus44.1% and 55.9% of total revenues, respectively, for the same period last year. Net income was $30.4 million versus net income of $21.5 million. The CEO commented:
- [By Peter Graham]
After the market closed yesterday, small cap restaurant and entertainment stockDave & Busters Entertainment Inc (NASDAQ: PLAY) reported Q4 2016 earnings with shares falling by mid single digit percentagesin after hours trading. The Company apparently beat expectations on earnings, but fell short of expectations for comps. Likewise, the stock has already had a very good run meaning expectations were super high.Take a look at the following long term chart which shows Dave & Busters Entertainmentsshare performanceascompared to potential peers such as Buffalo Wild Wings (NASDAQ: BWLD) and upscale gentlemen’s clubs and restaurant ownerRCI Hospitality Holdings, Inc (NASDAQ: RICK):
- [By Rich Duprey]
Yet as much as staying home and watching movies or television might be impacting Buffalo Wild Wings’ bottom line, it’s clear other factors are also at play, because where the beer-and-wings joint continues to report falling sales, rival Dave & Buster’s Entertainment(NASDAQ:PLAY) is see strong growth.
Top Clean Energy Stocks For 2018: Apache Corporation(APA)
Advisors’ Opinion:
- [By WWW.THESTREET.COM]
Cramer and Jack Mohr think Apache’s (APA) management has positioned the company for growth through both innovation and efficiency. Read what they are telling their investment club members with a free subscription to Action Alerts PLUS.
- [By WWW.THESTREET.COM]
Cramer and the Action Alerts PLUS team say they still believe in their embattled Permian names, Cimarex (XEC) and Apache (APA) , both of which have benefited from a slow rotation in recent weeks. These names can produce and profit here. Schlumberger (SLB) remains best in class and Magellan Midstream Partners just might be the best way to play oil given that the pipelines will be needed to transport the new wave of oil able to be drawn out of the ground from increasingly efficient American producers. Get in on the discussion by getting a free trial subscription to Action Alerts PLUS.
- [By WWW.THESTREET.COM]
Cramer and the AAP team say Apache’s (APA) mixed results are a buying opportunity. Find out what they’re telling their investment club members with a free trial subscription to Action Alerts PLUS.
- [By Lee Jackson]
These companies also reported insider buying last week: Apache Corp. (NYSE: APA), Halliburton Co. (NYSE: HAL), Revlon Inc. (NYSE: REV), Valeant Pharmaceuticals International Inc. (NYSE: VRX) and U.S. Steel Corp. (NYSE: X).
- [By WWW.THESTREET.COM]
Cramer and the AAP team are detailing their outlook for portfolio energy names Apache (APA) and Cimarex (XEC) . Find out what they’re telling their investment club members with a free trial subscription to Action Alerts PLUS.
Top Clean Energy Stocks For 2018: Entercom Communications Corporation(ETM)
Advisors’ Opinion:
- [By Peter Graham]
Small cap radio broadcasting stock Entercom Communications Corp (NYSE: ETM), a potential peer of Emmis Communications Corporation (NASDAQ: EMMS), Saga Communications (NYSEAMERICAN: SGA) and troubled Cumulus Media (NASDAQ: CMLS), is the tenth most shorted stock on the NYSE with short interest of 45.06% according to Highshortnterest.com.
Top Clean Energy Stocks For 2018: Sempra Energy(SRE)
Advisors’ Opinion:
- [By Lisa Levin]
Sempra Energy (NYSE: SRE) announced plans to acquire Oncor for $9.45 billion in cash.
Sempra Energy projects the deal to complete in the first half of 2018.
- [By WWW.THESTREET.COM]
The upgrade comes after Berkshire’s deal with Energy Future Holdings Corp to acquire its Oncor Electric Delivery interest was terminated Monday. Sempra Energy (SRE) agreed to buy Oncor for $9.45 billion, besting Berkshire’s $9 billion offer.
- [By Lisa Levin]
In trading on Friday, utilities shares fell by 0.93 percent. Meanwhile, top losers in the sector included Sempra Energy (NYSE: SRE), down 3 percent, and CenterPoint Energy, Inc. (NYSE: CNP), down 3 percent.
Top Clean Energy Stocks For 2018: EQT GP Holdings, LP(EQGP)
Advisors’ Opinion:
- [By Elizabeth Balboa]
Not only does Jana consider the deal price overvalued, but it looks to redirect EQT’s focus to a breakup of pipeline operations to transform the core company into an exploration & production firm. The pipelines already trade publicly under EQT Midstream Partners LP (NYSE: EQM) and EQT GP Holdings LP (NYSE: EQGP).
